Actome GmbH, a life science spin-off from Hahn-Schickard and the IMTEK laboratory for MEMS Application at the University of Freiburg, has convinced the expert jury of the European Innovation Council of its patented PICO technology: it is based on the recognition of individual protein molecules and protein interaction complexes and the translation of the protein status into DNA barcodes. The ampliﬁed DNA barcodes can be detected either by fluorescence measurement (dPCR) or next generation sequencing (NGS). The EIC Accelerator Program supports the development of new products that can be read by NGS. These new products will enable detection of a large number of targets. This research and development project is supported by Brussels with a research grant of approximately EUR 2.5 million and an equity contribution of approximately EUR 2.3 million.